Skip Navigation
Menu
Editorials |1 January 1995

Why Do Clinicians Continue to Debate the Use of Levothyroxine in the Diagnosis and Management of Thyroid Nodules?

Manfred Blum, MD

FULL TEXT
Why do clinicians still debate whether thyroid nodule volume decreases in response to therapy with levothyroxine, given that many types of nodules do not get smaller and that the therapy could have adverse effects [1]? The reasons include the enormous number of patients with enlarged thyroids, the myriad clinical variations of the condition, insecurity about clinical findings, exceptions to current diagnostic guidelines that identify malignancy, and questions about the long-term management of benign nodules or the contralateral lobe after surgery.
Suppressive therapy, in which thyroid hormone is administered to reduce the concentration of thyroid-stimulating hormone (TSH) to a level below normal (as opposed to replacement levothyroxine therapy, which normalizes the TSH level), had been used for years in the nonsurgical management of nodular thyroid disease [2-4]. However, this treatment is no longer popular: Recent studies failed to show efficacy [5, 6]; other studies showed an increased risk for osteoporosis as a consequence of thyrotoxicosis [7-9]; and fine-needle aspiration biopsy can better ascertain malignancy than can a therapeutic trial [10].
Although many patients do not need suppressive therapy, there are four main concerns about how the lack of suppressive therapy for cytologically benign disease may affect thyroid lesions or the patient's prognosis: First, in the past the clinician was alerted that a nodule might be malignant if it grew during treatment with levothyroxine. Enlargement of an untreated nodule is less informative. Second, because sampling errors from fine-needle aspiration biopsy may occur and negative or inconclusive cytologic...
FULL TEXT
PDF
Not Available
Citations
Citation

Blum M. Why Do Clinicians Continue to Debate the Use of Levothyroxine in the Diagnosis and Management of Thyroid Nodules?. Ann Intern Med. 1995;122:63–64. doi: https://doi.org/10.7326/0003-4819-122-1-199501010-00011

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1995;122(1):63-64.

DOI: 10.7326/0003-4819-122-1-199501010-00011

14 Citations

Related Articles
Update in Endocrinology
Annals of Internal Medicine; 142 (2): 126-131
In older adults with subclinical hypothyroidism, levothyroxine did not improve symptoms or tiredness
Annals of Internal Medicine; 167 (4): JC14
A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation
Annals of Internal Medicine; 159 (5): 325-332
Current use of levothyroxine was associated with increased risk for fractures in patients ≥ 70 years of age
Annals of Internal Medicine; 155 (6): JC3-5
View MoreView Less

Journal Club
In older adults with subclinical hypothyroidism, levothyroxine did not improve symptoms or tiredness
Annals of Internal Medicine; 167 (4): JC14
Current use of levothyroxine was associated with increased risk for fractures in patients ≥ 70 years of age
Annals of Internal Medicine; 155 (6): JC3-5
View MoreView Less

Related Topics
Endocrine and Metabolism
Endocrine Cancer
Hematology/Oncology
Thyroid Disorders

Endocrine and Metabolism, Endocrine Cancer, Hematology/Oncology, Thyroid Disorders.

PubMed Articles
Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component.
Med Sci Monit 2019;25():8492-8498.
The Clinicopathological Spectrum of Parathyroid Carcinoma.
Front Endocrinol (Lausanne) 2019;10():731.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×